Ram Gupta Selected Research

((2- hydroxy- 4- oxo- 6,7,8,9- tetrahydro- 4H,5H- 10- thia- 1,4a- diazabenzo(a)azulene- 3- carbonyl)amino)acetic acid

1/2014

Therapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ram Gupta Research Topics

Disease

2	Type 2 Diabetes Mellitus (MODY) 01/2011 - 07/2009
1	Hypoxia (Hypoxemia) 01/2014
1	Body Weight (Weight, Body) 01/2014
1	Colitis 01/2014
1	Crohn Disease (Crohn's Disease) 01/2014
1	Ulcerative Colitis 01/2014
1	Hypertension (High Blood Pressure) 01/2011
1	Obesity 01/2011
1	Diabetic Cardiomyopathies 07/2009
1	Heart Failure 07/2009
1	Hyperglycemia 07/2009
1	Diabetes Complications 07/2009
1	Renal Insufficiency (Renal Failure) 07/2009
1	Cerebral Infarction 08/2003

Drug/Important Bio-Agent (IBA)

1	Dextran SulfateIBA 01/2014
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2014
1	sym-trinitrobenzeneIBA 01/2014
1	((2- hydroxy- 4- oxo- 6,7,8,9- tetrahydro- 4H,5H- 10- thia- 1,4a- diazabenzo(a)azulene- 3- carbonyl)amino)acetic acidIBA 01/2014
1	Sulfonic AcidsIBA 01/2014
1	LDL CholesterolIBA 01/2011
1	TRC150094IBA 01/2011
1	Triglycerides (Triacylglycerol)IBA 01/2011
1	HDL CholesterolIBA 01/2011
1	3- ((2- (methylsulfonyl)hydrazino)carbonyl)- 1- (2- oxo- 2- thienylethyl)pyridiniumIBA 07/2009
1	Advanced Glycation End ProductsIBA 07/2009
1	triphenyltetrazoliumIBA 08/2003
1	Sodium SeleniteIBA 08/2003
1	Rutin (Rutoside)IBA 08/2003
1	allyl sulfideIBA 08/2003